Vineet Laboratories Share Price

Vineet Laboratories Share Price

NSE: VINEETLAB
|
Pharmaceuticals
|
S Cap
₹ 35.05
+₹0.24 (0.69%)
1D
Last updated 23 Sep, 2026, 13:29 IST

Vineet Laboratories Share Price Today

As of 23 Sep 2026, Vineet Laboratories share price is ₹35.05. The stock opened at ₹35.60, compared to its previous close of ₹34.81. During today's trading session, Vineet Laboratories share price moved in the range of ₹34.81 to ₹35.89, with an average price of ₹35.35 for the day. Looking at its last 52-week, the stock has touched a low of ₹27.96 and a high of ₹43.50. On the performance front, Vineet Laboratories share price has increased by 17.01% over the last six months and is down 3.60% on a year-on-year basis.

₹34.81
0.69% up today
₹35.89
1D LOW
1D HIGH

Vineet Laboratories Returns Calculator

Circuit
L
H
₹33.07
₹36.55
52-week
L
H
₹27.96
₹43.50

About Vineet Laboratories

Vineet Laboratories Share Price
ISIN
INE505Y01010
Sector Market Cap
₹ 66.20 Cr

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Vineet Laboratories Financial Highlights

  • Revenue: Vineet Laboratories reported revenue of ₹59.50 crore in FY26 vs ₹76.99 crore in FY25. It showed a decrease of 22.72% on a yearly basis.
  • Operating Profit: Vineet Laboratories reported an operating profit of ₹1.28 crore in FY26 vs ₹20.78 crore in FY25. It showed an increase of 106.16% on a year-on-year basis.
  • Net Profit: Vineet Laboratories reported a net profit of ₹1.11 crore in FY26 vs ₹20.19 crore in FY25. It showed an increase of 105.50% on a yearly basis.

Vineet Laboratories Quarterly Result Highlights

  • Vineet Laboratories reported revenue of ₹18.92 crore in Mar 2026, compared with ₹15.70 crore in Dec 2025, representing an increase of 20.51% on a quarter-on-quarter (QoQ) basis.
  • Vineet Laboratories reported an operating profit of ₹0.99 crore in Mar 2026, compared with ₹0.82 crore in Dec 2025, representing an increase of 20.73% on a quarter-on-quarter (QoQ) basis.
  • Vineet Laboratories reported a profit of ₹0.73 crore in Mar 2026, compared with ₹0.85 crore in Dec 2025, reflecting a decrease of 14.12% on a QoQ basis.
  • The earnings per share (EPS) of Vineet Laboratories stood at ₹21.90 during Mar 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
5.98%
FII
0.50%
Other DII
0.00%
Retail and other
93.52%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Feb 20260.00%
Mar 20260.36%
Jun 20260.50%
Mkt Cap Cr
66.20
P/E
59.43
P/B
1.45
ROE
2.44%
D/E
0.99
ROCE
6.78%
Div. Yield
0.00%
EPS(TTM)
1.00
Turnover
1.03
EV/EBITDA
11.25
Net Margin
0.00%
Op. Margin
0.00%
ROA
0.89%
Quick Ratio
0.00
Curr. Ratio
3.07
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Vineet Laborator has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Vineet Laborator appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Vineet Laboratories Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹75.00₹150.59₹212.29₹191.17
Other Income₹1.99₹0.46₹0.12₹0.29
Total Revenue₹76.98₹151.05₹212.42₹191.46
Total Expenses₹97.76₹150.69₹210.39₹182.11
Profit Before Tax-₹20.78₹0.36₹2.03₹9.35
Tax-₹0.58-₹0.66₹0.78₹2.71
Profit After Tax-₹20.19₹1.03₹1.25₹6.64
EPS - Basic-₹21.90₹1.11₹1.36₹7.16
EPS - Diluted-₹21.90₹1.11₹1.36₹7.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹20.78₹0.36₹2.03₹9.35
Income before WC changes-₹12.34₹7.15₹8.00₹13.25
Change in Assets₹21.13-₹1.21₹5.87-₹7.16
Change in Liabilities₹2.82-₹12.29-₹20.50₹4.72
Change in WC₹23.95-₹13.50-₹14.63-₹2.43
Cash flow from Operations₹11.49-₹6.61-₹9.62₹7.63
Cash flow from Investing-₹3.18-₹2.22-₹6.69-₹3.68
Cash flow from Financing-₹8.23₹8.43₹0.27₹11.96
Total Cash Flow₹0.08-₹0.40-₹16.03₹15.91
Cash (Start of the year)₹0.23₹0.63₹16.66₹0.75
Cash (End of the year)₹0.31₹0.23₹0.63₹16.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹27.15₹28.68₹28.39₹30.61
Current Assets₹67.39₹88.19₹87.46₹102.70
Total Assets₹94.54₹116.87₹115.85₹133.32
Current Liabilities₹74.39₹76.00₹74.51₹94.77
Net Current Asset-₹7.00₹12.19₹12.95₹7.94
Non-Current Liabilities₹5.50₹6.15₹7.66₹5.33
Equity Capital₹14.65₹34.72₹33.68₹33.22
Total Equity & Liabilities₹94.54₹116.87₹115.85₹133.32
* All values are in INR Crore
Qty
Bid
292
35
24
34.97
23
34.91
1000
34.9
200
34.82
Ask
Qty
35.05
20
35.08
24
35.09
70
35.12
57
35.13
2515
Bid Total: 1539
Ask Total: 2686
Buy orders: 36%
Sell orders: 64%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
38.48
Neutral
ATR (14)
1.89
Neutral
STOCH(9,6)
11.38
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
38.21
Bearish
UO(9)
50.38
Neutral
ROC(12)
-7.17
Bearish
WillR(14)
-89.03
Bullish
Period
Simple value
Exponential vaue
5D
35.8
35.67
10D
36.15
36.13
20D
37.16
36.69
50D
37.58
36.83
100D
36.17
36.14
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep1L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Vineet Laboratories Share Price
Vineet Laboratories
Pharmaceuticals
Add Stock
Add Another

Vineet Laboratories Share Price FAQs

Vineet Laboratories share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837